Real-time enrollment status for this idiopathic pulmonary fibrosis clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 8:24 PM UTC
| NCT Number | NCT07516951 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Pulmonary Fibrosis |
| Phase | PHASE2 |
| Target Enrollment | 240 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Chiesi Farmaceutici S.p.A. |
| Last Updated on CT.gov | October 16, 2026 (3 days ago) |
As of October 19, 2026: Clinical trial NCT07516951 is currently recruiting participants. This phase2 study for idiopathic pulmonary fibrosis is actively seeking new participants at 6 locations across the United States. The study is sponsored by Chiesi Farmaceutici S.p.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07516951 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07516951 was last updated 3 days ago (October 16, 2026). HelloStudys verifies this status automatically.